Methods To Determine the Silicone Oil Layer Thickness in Sprayed-On Siliconized Syringes

Reference

1. 1.↵
   1. Sacha G.,
   2. Rogers J. A.,
   3. Miller R.

   Pre-Filled Syringes: A Review of theHhistory, Manufacturing and Challenges. Pharm. Dev. Technol. 2015, 20 (1), 1–11.

   OpenUrl
2. 2.↵
   1. Sacha G.,
   2. Saffell-Clemmer W.,
   3. Abram K.,
   4. Akers M. J.

   Practical Fundamentals of Glass, Rubber, and Plastic Sterile Packaging Systems. Pharm. Dev. Technol. 2010, 15 (1), 6–34.

   OpenUrlPubMed
3. 3.↵
   F. Hoffmann-la-Roche Ltd. Qualifizierungsplan Layer Explorer Qsp0902, 2009.
4. 4.↵
   1. Rathore N.,
   2. Pranay P.,
   3. Eu B.,
   4. Ji W.,
   5. Walls E.

   Variability in Syringe Components and Its Impact on Functionality of Delivery Systems. PDA J. Pharm.Sci. Technol. 2011, 65 (5), 468–480.

   OpenUrl
5. 5.↵
   1. Jezek J.,
   2. Darton N. J.,
   3. Derham B. K.,
   4. Royle N.,
   5. Simpson I.

   Biopharmaceutical Formulations for Pre-Filled Delivery Devices. Expert Opin. Drug Del. 2013, 10 (6), 811–828.

   OpenUrl
6. 6.↵
   1. Vugmeyster Y.,
   2. Xu X.,
   3. Theil F.-P.,
   4. Khawli L. A.,
   5. Leach M. W.

   Pharmacokinetics and Toxicology of Therapeutic Proteins: Advances and Challenges. World J. Biol. Chem. 2012, 3 (4), 73–92.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Seidl A.,
   2. Hainzl O.,
   3. Richter M.,
   4. Fischer R.,
   5. Böhm S.,
   6. Deutel B.,
   7. Hartinger M.,
   8. Windisch J.,
   9. Casadevall N.,
   10. London G. M.,
   11. Macdougall I.

   Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity. Pharm. Res. 2012, 29 (6), 1454–1467.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Gascon P.

   Presently Available Biosimilars in Hematology-Oncology: G-CSF. Targeted Oncology 2012, 7 (1), 29–34.

   OpenUrl
9. 9.↵
   1. Funke S.,
   2. Matilainen J.,
   3. Nalenz H.,
   4. Bechtold-Peters K.,
   5. Mahler H. C.,
   6. Friess W.

   Analysis of Thin Baked-On Silicone Layers by FTIR and 3D-Laser Scanning Microscopy. Eur. J. Pharm. Biopharm. 2015, 96, 304–313.

   OpenUrl
10. 10.↵
    1. Depaz R. A.,
    2. Chevolleau T.,
    3. Jouffray S.,
    4. Narwal R.,
    5. Dimitrova M. N.

    Cross-Linked Silicone Coating: A Novel Prefilled Syringe Technology That Reduces Subvisible Particles and Maintains Compatibility with Biologics. J. Pharm. Sci. 2014, 103 (5), 1384–1393.

    OpenUrlPubMed
11. 11.↵
    1. Krayukhina E.,
    2. Tsumoto K.,
    3. Uchiyama S.,
    4. Fukui K.

    Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins. J. Pharm. Sci. 2014, 104 (2), 527–535.

    OpenUrl
12. 12.↵
    1. Colas A.,
    2. Siang J.,
    3. Ulman K.

    Siliconization of Parenteral Packaging Components. In Silicones in Pharmaceutical Applications; Dow Corning Corporation: Midland, MI, 2006.
13. 13.↵
    Parenteral Drug Association. Lubrication of Packaging Components Task Force. In Siliconization of Parenteral Drug Packaging Components. Parenteral Drug Association: Bethesda, MD, 1988; Vol 12.
14. 14.↵
    1. Badkar A.,
    2. Wolf A.,
    3. Bohack L.,
    4. Kolhe P.

    Development of Biotechnology Products in Pre-Filled Syringes: Technical Considerations and Approaches. AAPS PharmSciTech 2011, 12 (2), 564–572.

    OpenUrlPubMed
15. 15.↵
    European Pharmacopoeia Commission. European Pharmacopoeia; Council of Europe: Strasbourg, France, 2004; Vol 5.
16. 16.↵
    Dow Corning Corporation. Dow Corning 360 Medical Fluid product information (safety data sheet), 2015.
17. 17.↵
    1. Chan E.,
    2. Hubbard A.,
    3. Sane S.,
    4. Maa Y.

    F.Syringe Siliconization Process Investigation and Optimization. PDA J. Pharm. Sci. Technol. 2012, 66 (2), 136–150.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Bee J. S.,
    2. Frey V. V.,
    3. Javed U.,
    4. Chung J.,
    5. Corcoran M. L.,
    6. Roussel P. S.,
    7. Krause S. O.,
    8. Cash P. W.,
    9. Bishop S. M.,
    10. Dimitrova M. N.

    Characterization of the Initial Level and Migration of Silicone Oil Lubricant in Empty Prefilled Syringes for Biologics Using Infrared Spectroscopy. PDA J. Pharm. Sci. Technol. 2014, 68 (5), 494–503.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Lankers M.

    Analyse von Silikonschichtdicken bei der Herstellung von Fertigspritzen mit Hilfe von Reflektometriemessungen. Pharmazeutische Industrie 2010, 72 (12).
20. 20.
    1. Khandke L.,
    2. Malone R.,
    3. Yang X.,
    4. Han H.,
    5. Look J. L.,
    6. Jin Z.,
    7. Seid R. C. Jr..,
    8. Chen Y.

    Novel Formulations Which Stabilize and Inhibit Precipitation of Immunogenic Compositions. U.S. Patent 2011/0172393 A1, 2011.
21. 21.↵
    1. Yoshino K.,
    2. Arisa Yamashita N.,
    3. Abe Y.,
    4. Iwasaki K.,
    5. Kanazawa Y.,
    6. Funatsu K.,
    7. Yoshimoto T.,
    8. Suzuki S.

    Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System. J. Pharm. Sci. 2014, 103 (5), 1520–1528.

    OpenUrlPubMed
22. 22.↵
    1. Funke S.,
    2. Matilainen J,
    3. Nalenz H,
    4. Bechtold-Peters K,
    5. Mahler H. C,
    6. Friess W.

    Silicone Migration from Baked-On Silicone Layers. Particle Characterization in Placebo and Protein Solutions. J. Pharm. Sci. 2016, 105 (12), 3520–3531.

    OpenUrl
23. 23.↵
    1. Wen Z.-Q.,
    2. Vance A.,
    3. Vega F.,
    4. Cao X.,
    5. Eu B.,
    6. Schulthesis R.

    Distribution of Silicone Oil in Prefilled Glass Syringes Probed with Optical and Spectroscopic Methods. PDA J. Pharm. Sci. Technol. 2009, 63 (2), 149–158.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    European Committee for standardization. EN ISO 11040-4:2015 Prefilled syringes—Part 4: Glass barrels for injectables and sterilized subassembled syringes ready for filling. 2015.
25. 25.↵
    1. Funke S.,
    2. Matilainen J,
    3. Nalenz H,
    4. Bechtold-Peters K,
    5. Mahler H. C,
    6. Friess W.

    Optimization of the Bake-On Siliconization of Cartridges. Part I: Optimization of the Spray-On Parameters. Eur. J. Pharm. Biopharm. 2016, 104, 200–215.

    OpenUrl
26. 26.↵
    1. Felsovalyi F.,
    2. Janvier S.,
    3. Jouffray S.,
    4. Soukiassian H.,
    5. Mangiagalli P.

    Silicone-Oil-Based Subvisible Particles: Their Detection, Interactions, and Regulation in Prefilled Container Closure Systems for Biopharmaceuticals. J. Pharm. Sci. 2012, 101 (12), 4569–4583.

    OpenUrlPubMed
27. 27.↵
    1. Reuter B.

    Silicone Oil and Its Applications for Parenteral Products. PDA Europe Workshop, Cologne, Germany, 2010.
28. 28.↵
    1. Ingle R.,
    2. Agarwal A.

    Pre-Filled Syringe—A Ready-To-Use Drug Delivery System: A Review. Expert Opin. Drug Deliv. 2014, 11 (9), 1391–1399.

    OpenUrl
29. 29.↵
    Rap.ID Particle Systems GmbH. Technical Paper—How the Layer Explorer Works; Berlin, Germany, 2012.
30. 30.↵
    Rap.ID Particle Systems GmbH. Layer Explorer Operator's Manual. 2012.
31. 31.↵
    Rap.ID Particle Systems GmbH. Silicone Oil Layer Control. Available online: http://www.rap-id.com/premium_download/1006_DS_LE_e.pdf, accessed on April 13, 2018.
32. 32.↵
    1. Green P.,
    2. Silverman B.

    Nonparametric Regression and Generalized Linear Models: A Roughness Penalty Approach; CRC Press: Boca Raton, FL, 1993.
33. 33.↵
    1. Reuter B.,
    2. Petersen C.

    Syringe Siliconization—Trends, Methods, Analysis Procedures. TechnoPharm 2012, 2 (4), 238–244.

    OpenUrl
34. 34.↵
    1. Funke S.,
    2. Matilainen J.,
    3. Nalenz H.,
    4. Bechtold-Peters K.,
    5. Mahler HC.,
    6. Vetter F.,
    7. Müller C.,
    8. Bracher F.,
    9. Friess W.

    Optimization of the Bake-On Siliconization of Cartridges. Part II: Investigations into Burn-In Time and Temperature. Eur. J. Pharm. Biopharm. 2016, 105, 209–222.

    OpenUrl
35. 35.↵
    European Committee for Standardization. EN ISO 7886-3 Sterile hypodermic syringes for single use—Part 3: Auto-disable syringes for fixed-dose immunization. 2015.
36. 36.↵
    1. Joseph L.,
    2. Martin S.,
    3. Kohle P.,
    4. Muthurania K.

    Development of Syringeability Guide for Subcutaneous Protein Formulations. 2010; Available online: http://www.readbag.com/aapsj-abstracts-am-2010-w5265, accessed on June 15, 2016.
37. 37.↵
    1. Burckbuchler V.,
    2. Mekhloufi G.,
    3. Giteau A. P.,
    4. Grossiord J. L.,
    5. Huille S.,
    6. Agnely F.

    Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. Eur. J. Pharm. Biopharm. 2010, 76 (3), 351–356.

    OpenUrlPubMed
38. 38.↵
    1. Gerhardt A.,
    2. Mcgraw N. R.,
    3. Schwartz D. K.,
    4. Bee J. S.,
    5. Carpenter J. F.,
    6. Randolph T. W.

    Protein aggregation and particle formation in prefilled glass syringes. J. Pharm. Sci. 2014, 103 (6), 1601–1612.

    OpenUrl